CERVOMED ANNOUNCES NEFLAMAPIMOD AWARDED INNOVATION PASSPORT DESIGNATION UNDER THE UK INNOVATIVE LICENSING AND ACCESS PATHWAY (ILAP) FOR TREATMENT OF DEMENTIA WITH LEWY BODIES (DLB)

Reuters · 2d ago

Please log in to view news